Activity ID
13805Expires
October 29, 2027Format Type
EnduringCME Credit
0.25Fee
$30CME Provider: American Medical Association
Description of CME Course
As more states legalize, decriminalize, or otherwise increase access to cannabis for adult populations, there are also potential health implications for children and adolescents. Maria H. Rahmandar, MD, physician at Northwestern’s Feinberg School of Medicine, explores the risk factors, screening strategies, and impacts that cannabis use may have in this population.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Identify risk factors for cannabis use in children and adolescents
2. Describe patient-centric approaches to engaging and discussing cannabis use in children and adolescents
Keywords
Pediatrics, Adolescent Medicine, Substance Use and Addiction Medicine, Cannabinoids
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2024.0001188
